Efficacy and safety of dulaglutide vs metformin in type 2 diabetes (AWARD-3)

被引：0
|
作者：
Tofe Povedano, S. [1 ]
Umpierrez, G. [2 ]
Perez Manghi, F. [3 ]
Shurzinske, L. [4 ]
Pechtner, V. [5 ]
机构：
[1] Clin Juaneda, Palma De Mallorca, Spain
[2] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA USA
[3] Ctr Invest Metab CINME, Buenos Aires, DF, Argentina
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly & Co, Neuilly Sur Seine, France
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1) (vol 37, pg 2159, 2014)
    Wysham, Carol
    Blevins, Thomas
    Arakaki, Richard
    Colon, Gildred
    Garcia, Pedro
    Atisso, Charles
    Kuhstoss, Debra
    Lakshmanan, Mark
    DIABETES CARE, 2015, 38 (07)
  • [32] Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
    Nauck, Michael
    Weinstock, Ruth S.
    Umpierrez, Guillermo E.
    Guerci, Bruno
    Skrivanek, Zachary
    Milicevic, Zvonko
    DIABETES CARE, 2014, 37 (08) : 2149 - 2158
  • [33] Efficacy and Safety of Dulaglutide in Black/African Americans with Type 2 Diabetes: A Subgroup Analysis
    Wright, Eugene E., Jr.
    Botros, Fady T.
    Yu, Maria
    Garcia-Perez, Luis E.
    Razzoli, Elisa
    Jacobson, Jennie G.
    Thieu, Vivian
    DIABETES, 2017, 66 : A287 - A288
  • [34] Dose-finding results in an adaptive trial of dulaglutide combined with metformin in type 2 diabetes (AWARD-5)
    Skrivanek, Z.
    Chien, J. Y.
    Gaydos, B.
    Heathman, M.
    Geiger, M.
    Milicevic, Z.
    DIABETOLOGIA, 2013, 56 : S402 - S403
  • [35] Dose-Finding Results in an Adaptive Trial of Dulaglutide Combined With Metformin in Type 2 Diabetes (AWARD-5)
    Skrivanek, Zachary
    Chien, Jenny Y.
    Gaydos, Brenda
    Heathman, Michael
    Geiger, Mary Jane
    Milicevic, Zvonko
    DIABETES, 2013, 62 : A269 - A269
  • [36] Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes
    Gómez-Perez, FJ
    Fanghänel-Salmón, G
    Barbosa, JA
    Montes-Villarreal, J
    Berry, RA
    Warsi, G
    Gould, EM
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (02) : 127 - 134
  • [37] Efficacy and safety of combination therapy with vildagliptin and metformin vs, metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis
    Ding, Y.
    Liu, Y.
    Qu, Y.
    Lin, M.
    Dong, F.
    Li, Y.
    Cao, L.
    Lin, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (08) : 2802 - 2817
  • [38] Efficacy and safety of linagliptine in combination with metformin in patients with type 2 diabetes uncontrolled on metformin monotherapy
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Tocque-le Goussee, E.
    Woerle, H. -J.
    DIABETES & METABOLISM, 2011, 37 : A107 - A108
  • [39] Safety and efficacy of metformin XT to immediate-release metformin in patients with type 2 diabetes
    Niecestro, R
    Luckacsko, P
    Walters, E
    Sterman, A
    Friedhoff, L
    Isaacsohn, J
    DIABETES, 2002, 51 : A131 - A132
  • [40] Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic review
    Zhang, Lin
    Zhang, Mei
    Zhang, Yuwei
    Tong, Nanwei
    SCIENTIFIC REPORTS, 2016, 6
12345